Home › Skin Conditions › California
Skin Conditions clinical trials in California
13 studies for Skin Conditions are looking for participants at sites in California.
Cities in California
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
- Kern Research, Inc., Bakersfield
- First OC Dermatology Research Inc, Fountain Valley
- Northridge Clinical Trials, Northridge
- and 2 more
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Nov 12, 2026 · NCT07765888A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema
- Kern Research, Inc., Bakersfield
- First OC Dermatology Research Inc, Fountain Valley
- Marvel Clinical Research, Huntington Beach
- and 4 more
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Nov 6, 2026 · NCT07783425Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp
- Center for Dermatology Clinical Research, Inc, Fremont
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Nov 4, 2026 · NCT07144345A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
- California Dermatology & Clinical Research Institute, Encinitas
- Dermatology Research Associates, Los Angeles
- University of California, San Diego/Rady Children's Hospital, San Diego - Pediatric & Adolescent Dermatology, San Diego
- and 2 more
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Nov 4, 2026 · NCT05723198Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities
- Center for Dermatology Clinical Research, Inc, Fremont
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Nov 4, 2026 · NCT07144852A Study of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa (The SKYLIGHT Trial)
- Site 111, Irvine
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 19, 2026 · NCT07766005Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
- Amicis Research Center Valencia, Northridge
- Children'S Hospital of Orange County, Orange
- Clinical Trials Research Institute, Thousand Oaks
RecruitingPhase 1
Ages 12 to 75 · All sexes · Updated Oct 9, 2026 · NCT07049575(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- City of Hope Comprehensive Cancer Center, Duarte
- UCLA Medical Center, Los Angeles
- Stanford Cancer Institute, Stanford
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT04996875A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- Marvel Research, LLC, Huntington Beach
- Metropolis Dermatology, Los Angeles
- Dermatology Research Associates, Los Angeles
- and 4 more
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Aug 28, 2026 · NCT07599813A Phase II, Placebo Controlled, Clinical Trial of Topical TolaSure Targeting Aggregated Mutant Keratin in Epidermolysis Bullosa Simplex
- Stanford University School of Medicine, Dermatology Department, Palo Alto
RecruitingPhase 2
Ages 2 and older · All sexes · Updated Aug 13, 2026 · NCT07027345A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 1, Lancaster
- Inmagene Site 23, Los Angeles
RecruitingPhase 2
Ages 18 to 74 · All sexes · Updated Aug 12, 2026 · NCT07037901Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target
- Beckman Laser Institute and Medical Clinic, Irvine
- Dermatology Clinic at Gavin Herbert Eye Institute, Irvine
RecruitingObservational studyHealthy volunteers welcome
Ages 16 and older · All sexes · Updated Apr 13, 2026 · NCT00842283Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
- Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites, Culver City
RecruitingPhase 1/2Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Apr 29, 2022 · NCT04684602From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.